Willow Biosciences Inc's market cap is currently C$5.07M. The company's EPS TTM is C$-0.06; its P/E ratio is ―; Willow Biosciences Inc is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	C$ 1.17M	C$ 821.00K	C$ 133.00K	C$ 10.00K	C$ 4.58K
Gross Profit	C$ -659.00K	C$ -6.65M	C$ -11.40M	C$ 10.00K	C$ 4.58K
Operating Income	C$ -13.18M	C$ -18.39M	C$ -23.33M	C$ -23.06M	C$ -46.15M
EBITDA	C$ -11.06M	C$ -12.09M	C$ -2.92M	C$ -30.72M	C$ -43.93M
Net Income	C$ -13.03M	C$ -14.81M	C$ -6.17M	C$ -33.99M	C$ -44.57M
Balance Sheet
Cash & Short-Term Investments	C$ 3.17M	C$ 15.03M	C$ 30.12M	C$ 15.89M	C$ 19.73M
Total Assets	C$ 6.67M	C$ 18.15M	C$ 35.02M	C$ 21.86M	C$ 33.88M
Total Debt	C$ 2.16M	C$ 664.00K	C$ 802.00K	C$ 869.00K	C$ 1.20M
Net Debt	C$ -989.00K	C$ -10.34M	C$ -29.32M	C$ -15.03M	C$ -18.45M
Total Liabilities	C$ 3.24M	C$ 1.77M	C$ 5.33M	C$ 22.42M	C$ 11.87M
Stockholders' Equity	C$ 3.44M	C$ 16.37M	C$ 29.68M	C$ -559.00K	C$ 22.01M
Cash Flow
Free Cash Flow	C$ -11.54M	C$ -14.54M	C$ -19.99M	C$ -13.78M	C$ -15.87M
Operating Cash Flow	C$ -10.92M	C$ -13.86M	C$ -18.23M	C$ -12.78M	C$ -9.16M
Investing Cash Flow	C$ 3.46M	C$ -4.55M	C$ -1.67M	C$ -837.00K	C$ -6.83M
Financing Cash Flow	C$ -318.00K	C$ -723.00K	C$ 34.13M	C$ 9.89M	C$ 35.26M

Currency in CAD

Willow Biosciences Inc Earnings and Revenue History

Income Statement >

Willow Biosciences Inc Debt to Assets

Balance Sheet >

Willow Biosciences Inc Cash Flow

Cash Flow >

Willow Biosciences Inc Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing